Disc Medicine Ownership | Who Owns Disc Medicine?
Disc Medicine Ownership Summary
Disc Medicine is owned by 111.68% institutional investors, 7.74% insiders. Fmr is the largest institutional shareholder, holding 12.42% of IRON shares. Strategic Advisers Fidelity US TtlStk is the top mutual fund, with 4.96% of its assets in Disc Medicine shares.
IRON Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Disc Medicine | 111.68% | 7.74% | -19.43% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 4.80M | 12.42% | $314.41M |
| Blackrock funding, inc. /de | 2.53M | 6.55% | $165.80M |
| Ra capital management | 2.45M | 6.37% | $179.21M |
| Vanguard group | 1.77M | 5.02% | $140.37M |
| Price t rowe associates inc /md/ | 1.88M | 4.87% | $137.17M |
| Jpmorgan chase | 1.81M | 4.68% | $119.50M |
| Wellington management group llp | 1.74M | 4.52% | $127.36M |
| Vestal point capital, lp | 1.55M | 4.03% | $113.37M |
| State street | 1.41M | 3.63% | $92.00M |
| Atlas venture life science advisors | 1.38M | 3.58% | $90.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atlas venture life science advisors | 1.38M | 14.35% | $90.60M |
| Foresite capital management v | 374.07K | 7.55% | $27.36M |
| Checkpoint capital | 399.83K | 5.92% | $26.17M |
| Opaleye management | 855.00K | 5.66% | $62.53M |
| Saturn v capital management | 524.73K | 5.50% | $38.38M |
| Palo alto investors lp | 416.65K | 4.21% | $30.47M |
| Lion point capital, lp | 8.10K | 2.83% | $592.43K |
| Logos global management lp | 875.00K | 2.75% | $64.00M |
| Vestal point capital, lp | 1.55M | 2.65% | $113.37M |
| Tcg crossover management | 1.34M | 2.36% | $98.14M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 1.55M | 2.65% | 850.00K |
| Assenagon asset management | 1.12M | 0.07% | 735.30K |
| Opaleye management | 855.00K | 5.66% | 434.00K |
| Price t rowe associates inc /md/ | 1.88M | 0.01% | 326.05K |
| Vanguard group | 1.77M | 0.00% | 319.62K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | 247.72K | 0.47% | -963.25K |
| Orbimed advisors | 357.54K | 0.49% | -710.01K |
| Goldman sachs group | 97.38K | 0.00% | -542.46K |
| First light asset management | - | - | -523.17K |
| Perceptive advisors | - | - | -450.74K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Two sigma investments, lp | 136.75K | 0.01% | 136.75K | $10.00M |
| Trexquant investment lp | 107.70K | 0.05% | 107.70K | $7.88M |
| Pinnacle associates | 35.29K | 0.03% | 35.29K | $2.31M |
| Great lakes advisors | 28.72K | 0.01% | 28.72K | $1.88M |
| Mackenzie financial | 27.82K | 0.00% | 27.82K | $1.82M |
Sold Out
| Holder | Change |
|---|---|
| True wealth design | -1.00 |
| Wealth enhancement trust services | -1.00 |
| Twin peaks wealth advisors | -1.00 |
| Clearstead advisors | -2.00 |
| Mai capital management | -3.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 231 | 10.53% | 42,988,077 | 2.60% | 111 | 0.79% | 119 | -9.16% | 65 | 51.16% |
| Mar 31, 2026 | 205 | 3.02% | 41,801,986 | 9.16% | 118 | 1.00% | 128 | - | 43 | -12.24% |
| Dec 31, 2025 | 44 | -74.42% | 5,560,393 | -83.75% | 15 | 0.17% | 31 | -64.37% | 8 | -82.98% |
| Sep 30, 2025 | 51 | -66.45% | 3,188,170 | -90.64% | 9 | 0.10% | 26 | -73.20% | 13 | -63.89% |
| Jun 30, 2025 | 151 | -4.43% | 34,062,461 | 12.23% | 97 | 1.17% | 96 | -4.00% | 36 | 16.13% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Strategic Advisers Fidelity US TtlStk | 2.26M | 4.96% | 106.98K |
| Vanguard MStar Total Stk Mkt Idx Invest | 979.12K | 2.58% | 4.51K |
| Vanguard Total Stock Mkt Idx Inv | 971.12K | 2.54% | -13.85K |
| Vanguard Morn Total Stk Mkt Idx Investor | 971.12K | 2.54% | -13.85K |
| iShares Russell 2000 ETF | 829.47K | 1.82% | - |
| State Street® SPDR® S&P® Biotech ETF | 772.38K | 1.70% | 20.22K |
| JPM US Mid Cap Growth-Composite | 647.79K | 1.70% | 262.08K |
| US Small-Cap Growth II Equity Comp | 566.76K | 1.48% | 61.77K |
| JPMorgan Mid Cap Growth I | 650.90K | 1.43% | -10.33K |
| T. Rowe Price New Horizons | 459.25K | 1.20% | -56.91K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 10, 2026 | Savage William Jacob | Chief Medical Officer | Sell | $1.36M |
| Oct 20, 2026 | Bitterman Kevin | - | Sell | $190.92K |
| Oct 19, 2026 | Bitterman Kevin | - | Sell | $474.78K |
| Oct 20, 2026 | Bitterman Kevin | - | Sell | $229.38K |
| Oct 19, 2026 | Bitterman Kevin | - | Sell | $395.21K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 10 |
| 2026 Q3 | - | 27 |
| 2026 Q2 | - | 15 |
| 2026 Q1 | - | 15 |
| 2025 Q4 | - | 58 |
IRON Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools